Fierce Healthcare July 24, 2020
Two New York City metro health systems are collaborating with a startup to research the use of sensor-embedded clothing to monitor COVID-19 patients.
New Jersey-based Hackensack Meridian Health Systems and Maimonides Medical Center in Brooklyn, New York are working with Nanowear to use clinical-grade wearable technology—an undershirt with embedded nanosensors—to detect physiological and biomarker changes with patients either confirmed or suspected to have COVID-19.
Nanowear’s sensors can detect changes indicative of clinical deterioration that may require further intervention from the hospital systems, according to the company. In 2016, the New York City-based startup received clearance from the Food and Drug Administration (FDA) for its SimplECG, a remote cardiac monitoring undergarment.
The research collaboration with Hackensack and Maimonides involves Nanowear’s...